WHITE PETROLATUM

WHITE PETROLATUM was reported 1451 times

WHITE PETROLATUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LARGE CELL LUNG CANCER METASTATIC 2 0.1176
1 PNEUMONIA LIPOID 7 0.0511
2 EYELID EROSION 2 0.0230
3 ALVEOLAR RHABDOMYOSARCOMA 1 0.0227
4 DUODENAL NEOPLASM 2 0.0204
5 EXPOSURE VIA INHALATION 4 0.0185
6 ANAL EROSION 2 0.0182
7 ACANTHOLYSIS 1 0.0152
8 GASTROSTOMY TUBE SITE COMPLICATION 3 0.0150
9 MUCOCUTANEOUS RASH 2 0.0130
10 ACQUIRED HYDROCELE 1 0.0120
11 AMOEBIC COLITIS 1 0.0110
12 NEUROBLASTOMA 4 0.0104
13 BLOOD BETA-D-GLUCAN INCREASED 3 0.0098
14 ILIUM FRACTURE 2 0.0098
15 ZINC DEFICIENCY 2 0.0093
16 ECZEMA HERPETICUM 4 0.0086
17 URETHRAL DISORDER 4 0.0085
18 ADRENAL SUPPRESSION 6 0.0071
19 ERYTHEMA ANNULARE 2 0.0069
20 FIBRIN DEGRADATION PRODUCTS INCREASED 2 0.0068
21 LIP EXFOLIATION 8 0.0060
22 UPPER RESPIRATORY TRACT INFLAMMATION 7 0.0058
23 SEPTIC ARTHRITIS STAPHYLOCOCCAL 2 0.0057
24 LIP EROSION 4 0.0055
25 LICHENIFICATION 2 0.0049
26 VERTEBRAL OSTEOPHYTE 2 0.0047
27 CANDIDA SEPSIS 4 0.0045
28 FEEDING INTOLERANCE 2 0.0044
29 BIOPSY BONE MARROW 2 0.0043
30 ECZEMA ASTEATOTIC 2 0.0042
31 HYPOCHROMIC ANAEMIA 4 0.0039
32 ADENOIDAL DISORDER 1 0.0038
33 LIP PAIN 11 0.0038
34 OCCULT BLOOD 2 0.0038
35 LIP ERYTHEMA 3 0.0038
36 SEPTIC EMBOLUS 3 0.0036
37 BODY TINEA 2 0.0036
38 ENANTHEMA 2 0.0035
39 ENTEROVIRUS INFECTION 3 0.0035
40 LYMPHOCYTE MORPHOLOGY ABNORMAL 2 0.0035
41 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 3 0.0034
42 BLOOD UREA DECREASED 4 0.0032
43 CHONDROCALCINOSIS 2 0.0031
44 SKIN EROSION 9 0.0028
45 INFANTILE SPASMS 2 0.0028
46 VITAMIN B COMPLEX DEFICIENCY 2 0.0027
47 ANASTOMOTIC STENOSIS 1 0.0027
48 IMPETIGO 4 0.0027
49 STEROID DIABETES 4 0.0027
50 LIP DISORDER 5 0.0026
51 TRACHEITIS 2 0.0026
52 PULMONARY ARTERY THROMBOSIS 2 0.0026
53 PSEUDOMONAS TEST POSITIVE 2 0.0024
54 APPLICATION SITE LACERATION 1 0.0024
55 INSULIN RESISTANCE 5 0.0024
56 ANXIETY DISORDER 8 0.0024
57 LIP PRURITUS 2 0.0023
58 LIP INJURY 3 0.0023
59 ANAEMIA OF CHRONIC DISEASE 2 0.0022
60 ANASTOMOTIC ULCER 1 0.0022
61 KLEBSIELLA BACTERAEMIA 2 0.0021
62 BLOOD URINE 2 0.0021
63 CONJUNCTIVITIS ALLERGIC 3 0.0020
64 CHOLANGIOCARCINOMA 3 0.0020
65 IMMUNE-MEDIATED DERMATITIS 2 0.0020
66 ILEAL ULCER 2 0.0020
67 MARASMUS 3 0.0020
68 CANCER PAIN 5 0.0020
69 CORONAVIRUS TEST POSITIVE 2 0.0019
70 MONOCYTE COUNT INCREASED 7 0.0019
71 HYPOPERFUSION 2 0.0019
72 OVARIAN CANCER RECURRENT 3 0.0019
73 METASTATIC NEOPLASM 8 0.0019
74 CHAPPED LIPS 8 0.0018
75 LIP BLISTER 5 0.0018
76 PELVIC ABSCESS 2 0.0017
77 PULMONARY TOXICITY 12 0.0017
78 PUSTULE 4 0.0017
79 PNEUMONIA INFLUENZAL 2 0.0017
80 OTITIS EXTERNA 2 0.0016
81 VESTIBULAR DISORDER 2 0.0016
82 ORAL MUCOSA EROSION 2 0.0016
83 RHINITIS ALLERGIC 7 0.0016
84 PLATELET TRANSFUSION 2 0.0016
85 APPLICATION SITE EROSION 2 0.0016
86 PNEUMONIA CYTOMEGALOVIRAL 3 0.0015
87 ABDOMINAL WALL ABSCESS 1 0.0015
88 PACKED RED BLOOD CELL TRANSFUSION 2 0.0015
89 GASTROENTERITIS NOROVIRUS 2 0.0015
90 DERMATITIS ACNEIFORM 9 0.0015
91 CHEILITIS 8 0.0015
92 EYELID PAIN 3 0.0015
93 CHOLANGITIS SCLEROSING 3 0.0015
94 AORTITIS 1 0.0015
95 INFUSION SITE RASH 2 0.0015
96 BEZOAR 2 0.0014
97 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
98 SUDDEN ONSET OF SLEEP 2 0.0014
99 PERIPHERAL MOTOR NEUROPATHY 2 0.0014
100 SKIN INFECTION 16 0.0014
101 IRON DEFICIENCY ANAEMIA 13 0.0014
102 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
103 SPUTUM INCREASED 3 0.0014
104 PERIODONTITIS 3 0.0014
105 NODAL RHYTHM 2 0.0014
106 PSEUDOMEMBRANOUS COLITIS 3 0.0013
107 COELIAC DISEASE 13 0.0013
108 RHINOVIRUS INFECTION 5 0.0013
109 AORTIC DISORDER 1 0.0013
110 TINEA PEDIS 2 0.0013
111 OPTIC NERVE DISORDER 2 0.0012
112 COLON CANCER METASTATIC 2 0.0012
113 SEBORRHOEIC DERMATITIS 2 0.0012
114 PNEUMONIA BACTERIAL 11 0.0012
115 MALIGNANT PLEURAL EFFUSION 2 0.0012
116 BACTERAEMIA 14 0.0012
117 ACUTE SINUSITIS 2 0.0012
118 BLOOD CHLORIDE INCREASED 2 0.0012
119 SCHIZOPHRENIA 14 0.0012
120 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
121 BURNS SECOND DEGREE 2 0.0011
122 PARONYCHIA 5 0.0011
123 BRONCHIOLITIS 4 0.0011
124 SKIN WEEPING 4 0.0011
125 UTERINE POLYP 2 0.0011
126 DECUBITUS ULCER 9 0.0011
127 SINUS NODE DYSFUNCTION 2 0.0011
128 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
129 POOR QUALITY DRUG ADMINISTERED 7 0.0011
130 LYMPH NODE PAIN 2 0.0011
131 ADENOCARCINOMA OF COLON 2 0.0011
132 DISSEMINATED INTRAVASCULAR COAGULATION 15 0.0011
133 PEMPHIGOID 8 0.0011
134 CATHETER SITE INFECTION 4 0.0011
135 BONE MARROW TRANSPLANT 2 0.0011
136 PNEUMATOSIS INTESTINALIS 3 0.0011
137 ACTINOMYCOSIS 1 0.0010
138 ENTEROCOLITIS 6 0.0010
139 HAEMOTHORAX 3 0.0010
140 IMMUNE-MEDIATED HEPATIC DISORDER 2 0.0010
141 ANTIBIOTIC THERAPY 1 0.0010
142 VITAMIN D DEFICIENCY 10 0.0010
143 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
144 CONCOMITANT DISEASE PROGRESSION 2 0.0010
145 HEPATITIS FULMINANT 3 0.0010
146 BLEPHARITIS 4 0.0010
147 IMMUNE-MEDIATED HEPATITIS 2 0.0010
148 ACUTE PROMYELOCYTIC LEUKAEMIA 1 0.0010
149 HYPERURICAEMIA 4 0.0010
150 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
151 PORTAL HYPERTENSION 3 0.0010
152 COMPULSIVE SHOPPING 2 0.0010
153 BLOOD BILIRUBIN INCREASED 26 0.0010
154 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
155 APPLICATION SITE SCAB 2 0.0009
156 HORDEOLUM 4 0.0009
157 REACTION TO DRUG EXCIPIENTS 2 0.0009
158 DIABETIC NEPHROPATHY 2 0.0009
159 OTITIS MEDIA 3 0.0009
160 ADRENAL INSUFFICIENCY 11 0.0009
161 AORTIC DILATATION 1 0.0009
162 LARGE INTESTINAL OBSTRUCTION 2 0.0009
163 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
164 LIP DRY 8 0.0009
165 PNEUMONIA ASPIRATION 22 0.0009
166 ORAL PRURITUS 2 0.0009
167 PRIAPISM 3 0.0009
168 GRANULOMA 3 0.0009
169 AORTIC THROMBOSIS 1 0.0009
170 TOXIC EPIDERMAL NECROLYSIS 13 0.0009
171 SPINAL COMPRESSION FRACTURE 7 0.0008
172 DRUG ERUPTION 15 0.0008
173 PULMONARY INFARCTION 2 0.0008
174 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
175 ACUTE LUNG INJURY 1 0.0008
176 FIBRIN D DIMER INCREASED 3 0.0008
177 ACCIDENT 10 0.0008
178 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
179 DERMAL CYST 2 0.0008
180 CELLULITIS 41 0.0008
181 HYPOPHOSPHATAEMIA 6 0.0008
182 HYPERVOLAEMIA 4 0.0008
183 PYELONEPHRITIS 7 0.0008
184 LEUKOENCEPHALOPATHY 3 0.0008
185 INTRAVENTRICULAR HAEMORRHAGE 2 0.0008
186 CATHETER SITE HAEMORRHAGE 2 0.0008
187 EYELID IRRITATION 2 0.0008
188 URINARY TRACT INFECTION BACTERIAL 2 0.0008
189 GINGIVAL DISORDER 3 0.0008
190 HEPATOSPLENOMEGALY 2 0.0008
191 PHYSICAL DECONDITIONING 2 0.0008
192 DRUG TITRATION ERROR 2 0.0008
193 ADJUSTMENT DISORDER 1 0.0008
194 STEVENS-JOHNSON SYNDROME 17 0.0008
195 PNEUMONIA FUNGAL 3 0.0008
196 SERUM FERRITIN INCREASED 4 0.0008
197 ACROCHORDON 1 0.0008
198 BLOOD SODIUM INCREASED 2 0.0007
199 GAMBLING DISORDER 2 0.0007
200 INVASIVE DUCTAL BREAST CARCINOMA 2 0.0007
201 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
202 BLOOD PHOSPHORUS INCREASED 2 0.0007
203 ABSCESS ORAL 1 0.0007
204 ILEUS 9 0.0007
205 GASTRIC ULCER HAEMORRHAGE 4 0.0007
206 SKIN HYPERTROPHY 2 0.0007
207 PURULENT DISCHARGE 3 0.0007
208 BLOOD URIC ACID INCREASED 4 0.0007
209 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
210 ADENOVIRUS INFECTION 2 0.0007
211 COVID-19 PNEUMONIA 8 0.0007
212 ILEUS PARALYTIC 3 0.0007
213 NORMOCHROMIC NORMOCYTIC ANAEMIA 2 0.0007
214 GANGRENE 4 0.0007
215 DELIRIUM 23 0.0007
216 MYELOFIBROSIS 2 0.0007
217 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
218 KERATITIS 2 0.0007
219 FEBRILE NEUTROPENIA 43 0.0006
220 PIGMENTATION DISORDER 4 0.0006
221 CHOLANGITIS 4 0.0006
222 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 15 0.0006
223 ERYTHEMA MULTIFORME 6 0.0006
224 HEPATIC FUNCTION ABNORMAL 24 0.0006
225 NON-SMALL CELL LUNG CANCER 3 0.0006
226 ANALGESIC DRUG LEVEL INCREASED 1 0.0006
227 APHAGIA 3 0.0006
228 ENTEROCOCCAL INFECTION 3 0.0006
229 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
230 BACTERIAL SEPSIS 2 0.0006
231 HEPATOMEGALY 6 0.0006
232 HYPOGAMMAGLOBULINAEMIA 4 0.0006
233 DEAFNESS NEUROSENSORY 2 0.0006
234 ANTIBODY TEST POSITIVE 1 0.0006
235 CARDIAC FAILURE ACUTE 4 0.0006
236 CORONARY ARTERY STENOSIS 3 0.0006
237 DYSLIPIDAEMIA 3 0.0006
238 HEPATIC CYST 2 0.0006
239 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
240 ORAL DISCOMFORT 8 0.0006
241 ACUTE RESPIRATORY FAILURE 11 0.0006
242 SCRATCH 6 0.0006
243 DUODENAL ULCER 4 0.0006
244 JAUNDICE CHOLESTATIC 2 0.0006
245 HAEMORRHOIDS 11 0.0006
246 THERMAL BURN 4 0.0006
247 SKIN FISSURES 11 0.0006
248 HAEMORRHAGIC DIATHESIS 2 0.0006
249 RETINAL HAEMORRHAGE 4 0.0006
250 CONJUNCTIVAL HYPERAEMIA 2 0.0006
251 PYODERMA GANGRENOSUM 2 0.0006
252 FACIAL BONES FRACTURE 2 0.0006
253 ERYTHEMA OF EYELID 3 0.0006
254 VISUAL FIELD DEFECT 4 0.0006
255 DERMATITIS BULLOUS 4 0.0006
256 OESOPHAGITIS 6 0.0005
257 IMMUNE-MEDIATED ENTEROCOLITIS 2 0.0005
258 URINARY RETENTION 18 0.0005
259 HYDRONEPHROSIS 4 0.0005
260 PERONEAL NERVE PALSY 3 0.0005
261 SCAB 6 0.0005
262 DERMATITIS 11 0.0005
263 CARDIAC VALVE DISEASE 3 0.0005
264 THYROID MASS 2 0.0005
265 ELECTROLYTE IMBALANCE 6 0.0005
266 NEUTROPHIL COUNT DECREASED 21 0.0005
267 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
268 PRODUCT COMPLAINT 13 0.0005
269 DERMATITIS ATOPIC 27 0.0005
270 BLOOD ALBUMIN DECREASED 4 0.0005
271 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
272 AZOTAEMIA 2 0.0005
273 SKIN PAPILLOMA 2 0.0005
274 CYSTITIS HAEMORRHAGIC 2 0.0005
275 EMPHYSEMA 5 0.0005
276 RECURRENT CANCER 2 0.0005
277 PERIPHERAL ISCHAEMIA 2 0.0005
278 ARTHRITIS BACTERIAL 2 0.0005
279 SELF-MEDICATION 2 0.0005
280 HYPERCALCAEMIA 6 0.0005
281 PHARYNGITIS 6 0.0005
282 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
283 SEPTIC SHOCK 21 0.0005
284 GASTROINTESTINAL PERFORATION 2 0.0005
285 SECOND PRIMARY MALIGNANCY 4 0.0005
286 PLEURAL EFFUSION 29 0.0005
287 ONYCHOMADESIS 2 0.0005
288 AORTIC VALVE INCOMPETENCE 2 0.0005
289 ENTERITIS 3 0.0005
290 PULMONARY TUBERCULOSIS 2 0.0005
291 VITAMIN D DECREASED 4 0.0005
292 C-REACTIVE PROTEIN ABNORMAL 3 0.0005
293 C-REACTIVE PROTEIN INCREASED 17 0.0005
294 ANURIA 4 0.0005
295 APPLICATION SITE VESICLES 3 0.0005
296 OCULAR ICTERUS 2 0.0005
297 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
298 PLATELET COUNT INCREASED 6 0.0005
299 TONGUE DISCOLOURATION 2 0.0005
300 PULMONARY FUNCTION TEST DECREASED 2 0.0005
301 TUMOUR LYSIS SYNDROME 4 0.0005
302 INTERSTITIAL LUNG DISEASE 22 0.0005
303 APPLICATION SITE PAIN 10 0.0005
304 PURPURA 4 0.0005
305 LIP SWELLING 15 0.0004
306 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
307 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
308 MALNUTRITION 5 0.0004
309 ADENOCARCINOMA 1 0.0004
310 PAPILLOEDEMA 2 0.0004
311 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
312 PNEUMOTHORAX 7 0.0004
313 ABNORMAL LOSS OF WEIGHT 3 0.0004
314 DERMATITIS CONTACT 5 0.0004
315 ACUTE GRAFT VERSUS HOST DISEASE 2 0.0004
316 ISCHAEMIA 2 0.0004
317 APHTHOUS STOMATITIS 1 0.0004
318 PERICARDIAL EFFUSION 10 0.0004
319 CONJUNCTIVITIS 8 0.0004
320 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
321 SKIN TIGHTNESS 2 0.0004
322 VAGINAL INFECTION 2 0.0004
323 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
324 ATELECTASIS 4 0.0004
325 HYPERGLYCAEMIA 15 0.0004
326 GASTROENTERITIS 6 0.0004
327 HYPOTHYROIDISM 13 0.0004
328 BREATH SOUNDS ABNORMAL 2 0.0004
329 STAPHYLOCOCCAL SEPSIS 2 0.0004
330 LIGAMENT SPRAIN 4 0.0004
331 ACUTE PSYCHOSIS 1 0.0004
332 FOOT OPERATION 2 0.0004
333 DIABETIC NEUROPATHY 2 0.0004
334 ORGANISING PNEUMONIA 2 0.0004
335 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 2 0.0004
336 HYPERAMMONAEMIA 2 0.0004
337 FLUID INTAKE REDUCED 2 0.0004
338 DYSPHORIA 2 0.0004
339 TOXIC ENCEPHALOPATHY 2 0.0004
340 ACIDOSIS 3 0.0004
341 AMMONIA INCREASED 2 0.0004
342 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
343 CACHEXIA 2 0.0004
344 AORTIC ARTERIOSCLEROSIS 1 0.0004
345 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
346 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
347 FAILURE TO THRIVE 2 0.0004
348 ACUTE MYELOID LEUKAEMIA 6 0.0004
349 ANGINA PECTORIS 11 0.0004
350 ECZEMA 20 0.0004
351 ATRIAL FLUTTER 3 0.0004
352 ANIMAL BITE 1 0.0004
353 ALCOHOL ABUSE 1 0.0004
354 CARDIAC FAILURE 30 0.0004
355 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
356 ANAL FISSURE 2 0.0004
357 GINGIVITIS 2 0.0004
358 HYPOKALAEMIA 17 0.0004
359 APPLICATION SITE HAEMORRHAGE 1 0.0004
360 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
361 MELAENA 8 0.0004
362 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
363 DENTAL CARIES 4 0.0004
364 VENTRICULAR FIBRILLATION 4 0.0004
365 BLOOD UREA INCREASED 6 0.0004
366 ANAL HAEMORRHAGE 1 0.0004
367 MACULAR OEDEMA 2 0.0004
368 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
369 BLOOD MAGNESIUM DECREASED 3 0.0003
370 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
371 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
372 RALES 2 0.0003
373 HYPOXIA 12 0.0003
374 SEPSIS 38 0.0003
375 LYMPHOCYTE COUNT DECREASED 6 0.0003
376 DECREASED INTEREST 2 0.0003
377 PLEURISY 2 0.0003
378 PULMONARY HYPERTENSION 7 0.0003
379 SYMPTOM RECURRENCE 2 0.0003
380 DEVICE RELATED INFECTION 5 0.0003
381 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
382 OLIGURIA 2 0.0003
383 SQUAMOUS CELL CARCINOMA 3 0.0003
384 SWELLING OF EYELID 2 0.0003
385 PRODUCT USE COMPLAINT 5 0.0003
386 PHOTOPSIA 2 0.0003
387 OBESITY 5 0.0003
388 CHOLESTASIS 6 0.0003
389 SKIN EXFOLIATION 26 0.0003
390 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
391 PLATELET COUNT DECREASED 32 0.0003
392 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
393 TOXIC SKIN ERUPTION 3 0.0003
394 BRONCHIECTASIS 2 0.0003
395 TOOTH ABSCESS 3 0.0003
396 NEUTROPHIL COUNT INCREASED 3 0.0003
397 LUNG NEOPLASM MALIGNANT 12 0.0003
398 NEPHROTIC SYNDROME 2 0.0003
399 ONYCHOCLASIS 2 0.0003
400 VENTRICULAR EXTRASYSTOLES 3 0.0003
401 LARGE INTESTINE POLYP 2 0.0003
402 RESPIRATORY FAILURE 21 0.0003
403 TENDERNESS 3 0.0003
404 AUTOIMMUNE HEPATITIS 2 0.0003
405 HYPOMAGNESAEMIA 4 0.0003
406 PRODUCT ODOUR ABNORMAL 3 0.0003
407 RIGHT VENTRICULAR FAILURE 2 0.0003
408 HYPERKALAEMIA 10 0.0003
409 APPLICATION SITE REACTION 2 0.0003
410 HYPONATRAEMIA 16 0.0003
411 PAPULE 2 0.0003
412 SEASONAL ALLERGY 4 0.0003
413 DIVERTICULUM 2 0.0003
414 APPENDICECTOMY 1 0.0003
415 NEUTROPENIC SEPSIS 2 0.0003
416 GRAFT VERSUS HOST DISEASE 2 0.0003
417 PANIC REACTION 2 0.0003
418 MYELODYSPLASTIC SYNDROME 4 0.0003
419 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
420 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
421 ASCITES 8 0.0003
422 AMYLASE INCREASED 1 0.0003
423 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
424 SKIN HAEMORRHAGE 4 0.0003
425 ARTHROPOD BITE 2 0.0003
426 OCULAR DISCOMFORT 3 0.0003
427 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
428 BLOOD SODIUM DECREASED 5 0.0003
429 HYPOCALCAEMIA 5 0.0003
430 STOMATITIS 16 0.0003
431 FOOT FRACTURE 5 0.0003
432 DEHYDRATION 35 0.0003
433 SLEEP APNOEA SYNDROME 5 0.0003
434 RENAL IMPAIRMENT 22 0.0003
435 HAEMOLYSIS 2 0.0003
436 VASCULITIS 3 0.0003
437 HYPOALBUMINAEMIA 2 0.0003
438 PULMONARY HAEMORRHAGE 2 0.0003
439 DRUG-INDUCED LIVER INJURY 8 0.0003
440 DRY SKIN 34 0.0003
441 SINUS DISORDER 5 0.0003
442 FURUNCLE 2 0.0003
443 RENAL CYST 2 0.0003
444 ANAEMIA 48 0.0003
445 CEREBRAL HAEMORRHAGE 9 0.0003
446 MACULAR DEGENERATION 3 0.0003
447 HYPERLIPIDAEMIA 3 0.0003
448 BLISTER 14 0.0002
449 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
450 PYREXIA 86 0.0002
451 RHINITIS 2 0.0002
452 STENT PLACEMENT 2 0.0002
453 FEEDING DISORDER 5 0.0002
454 APPLICATION SITE DISCOLOURATION 1 0.0002
455 SHOCK HAEMORRHAGIC 2 0.0002
456 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
457 CARDIOMEGALY 3 0.0002
458 METASTASES TO BONE 4 0.0002
459 HICCUPS 2 0.0002
460 BRONCHITIS 18 0.0002
461 ESCHERICHIA INFECTION 2 0.0002
462 APPLICATION SITE EXFOLIATION 1 0.0002
463 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
464 EMBOLISM 2 0.0002
465 HEMIPLEGIA 2 0.0002
466 SECRETION DISCHARGE 3 0.0002
467 COLITIS 9 0.0002
468 DEPENDENCE 13 0.0002
469 GASTRIC CANCER 6 0.0002
470 RESPIRATORY DISORDER 7 0.0002
471 PSEUDOMONAS INFECTION 2 0.0002
472 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
473 LIVER FUNCTION TEST INCREASED 5 0.0002
474 INJECTION SITE INDURATION 3 0.0002
475 WHITE BLOOD CELL COUNT DECREASED 25 0.0002
476 FAECES DISCOLOURED 5 0.0002
477 RESPIRATORY TRACT INFECTION 6 0.0002
478 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
479 URINE OUTPUT DECREASED 2 0.0002
480 NAIL DISORDER 2 0.0002
481 GASTRITIS 6 0.0002
482 SPINAL OSTEOARTHRITIS 2 0.0002
483 GRIP STRENGTH DECREASED 2 0.0002
484 IMMUNOSUPPRESSION 2 0.0002
485 LUNG INFILTRATION 2 0.0002
486 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
487 ABDOMINAL ABSCESS 1 0.0002
488 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
489 LIVER DISORDER 10 0.0002
490 RASH MACULO-PAPULAR 5 0.0002
491 HEPATOTOXICITY 5 0.0002
492 FACIAL PAIN 2 0.0002
493 HAEMOGLOBIN DECREASED 23 0.0002
494 HAEMOLYTIC ANAEMIA 2 0.0002
495 HAEMARTHROSIS 2 0.0002
496 OROPHARYNGEAL DISCOMFORT 2 0.0002
497 LEUKOCYTOSIS 4 0.0002
498 TACHYPNOEA 3 0.0002
499 ACUTE HEPATIC FAILURE 3 0.0002
500 PNEUMONIA 71 0.0002
501 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
502 URINARY TRACT INFECTION 37 0.0002
503 OVARIAN CANCER 2 0.0002
504 HAEMOPTYSIS 6 0.0002
505 APHONIA 3 0.0002
506 WOUND 6 0.0002
507 DEFORMITY 2 0.0002
508 PHOTOPHOBIA 4 0.0002
509 LEUKAEMIA 2 0.0002
510 PAIN IN JAW 6 0.0002
511 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
512 INFUSION RELATED REACTION 14 0.0002
513 SPUTUM DISCOLOURED 2 0.0002
514 NEUROPATHY PERIPHERAL 20 0.0002
515 EYE INFLAMMATION 2 0.0002
516 PULMONARY FIBROSIS 4 0.0002
517 GLAUCOMA 4 0.0002
518 HYPERCHOLESTEROLAEMIA 2 0.0002
519 HYPOGLYCAEMIA 10 0.0002
520 ORAL HERPES 4 0.0002
521 CEREBRAL INFARCTION 5 0.0002
522 HAEMATURIA 7 0.0002
523 VITREOUS FLOATERS 2 0.0002
524 HOSPICE CARE 2 0.0002
525 PULMONARY MASS 3 0.0002
526 ABDOMINAL TENDERNESS 1 0.0002
527 COLON CANCER 3 0.0002
528 PULMONARY OEDEMA 9 0.0002
529 APPLICATION SITE SWELLING 1 0.0002
530 EPISTAXIS 15 0.0002
531 OVARIAN CYST 2 0.0002
532 ERYTHEMA 41 0.0002
533 CYTOKINE RELEASE SYNDROME 4 0.0002
534 HAEMATOCHEZIA 11 0.0002
535 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
536 HYPOTHERMIA 2 0.0002
537 RASH 86 0.0002
538 TASTE DISORDER 4 0.0002
539 PANCYTOPENIA 11 0.0002
540 SUBARACHNOID HAEMORRHAGE 2 0.0002
541 HYPOPHAGIA 5 0.0002
542 MUSCULOSKELETAL CHEST PAIN 3 0.0002
543 DECREASED APPETITE 45 0.0002
544 FEMUR FRACTURE 6 0.0002
545 HYPERBILIRUBINAEMIA 2 0.0002
546 EYE DISCHARGE 2 0.0002
547 INJECTION SITE DISCOMFORT 2 0.0002
548 RESPIRATORY TRACT CONGESTION 3 0.0002
549 OEDEMA PERIPHERAL 23 0.0002
550 ULCER 3 0.0002
551 CYSTITIS 6 0.0002
552 CONSTIPATION 41 0.0002
553 METABOLIC ACIDOSIS 6 0.0002
554 PAIN OF SKIN 5 0.0002
555 BLOOD POTASSIUM INCREASED 3 0.0002
556 DEEP VEIN THROMBOSIS 12 0.0002
557 OEDEMA 10 0.0002
558 SKIN LACERATION 2 0.0002
559 BLOOD CREATININE INCREASED 12 0.0002
560 PNEUMONITIS 5 0.0002
561 WOUND INFECTION 2 0.0002
562 STAPHYLOCOCCAL INFECTION 6 0.0002
563 GASTROINTESTINAL PAIN 2 0.0002
564 VENTRICULAR TACHYCARDIA 3 0.0002
565 MENTAL STATUS CHANGES 5 0.0002
566 TRANSAMINASES INCREASED 4 0.0002
567 SKIN DISORDER 6 0.0002
568 ORAL PAIN 4 0.0002
569 EYE PRURITUS 6 0.0002
570 PERICARDITIS 3 0.0002
571 TYPE 2 DIABETES MELLITUS 6 0.0002
572 PANCREATITIS ACUTE 4 0.0002
573 FACE OEDEMA 3 0.0002
574 CANDIDA INFECTION 3 0.0002
575 EYE PAIN 10 0.0002
576 REBOUND EFFECT 2 0.0002
577 MITRAL VALVE INCOMPETENCE 2 0.0002
578 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
579 INTERNAL HAEMORRHAGE 2 0.0002
580 MYOCARDITIS 2 0.0002
581 SHOCK 4 0.0002
582 GASTRIC HAEMORRHAGE 2 0.0002
583 METASTASES TO LUNG 2 0.0002
584 DYSPEPSIA 17 0.0002
585 EYELID OEDEMA 2 0.0002
586 MUSCULOSKELETAL PAIN 9 0.0002
587 SPLENOMEGALY 2 0.0002
588 SPINAL PAIN 2 0.0002
589 METASTASES TO LIVER 3 0.0002
590 ACUTE KIDNEY INJURY 26 0.0002
591 BRADYCARDIA 9 0.0002
592 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
593 TACHYCARDIA 15 0.0002
594 CHOLECYSTITIS 2 0.0002
595 RASH ERYTHEMATOUS 8 0.0002
596 BLOOD POTASSIUM DECREASED 5 0.0002
597 TOOTHACHE 3 0.0002
598 HEPATITIS C 2 0.0002
599 BLOOD PRESSURE DECREASED 11 0.0002
600 NEURALGIA 4 0.0002
601 PRURITUS 63 0.0002
602 RESPIRATORY DEPRESSION 2 0.0002
603 INJECTION SITE EXTRAVASATION 2 0.0002
604 GENERALISED OEDEMA 2 0.0002
605 BACTERIAL INFECTION 3 0.0002
606 DRY EYE 8 0.0002
607 OXYGEN SATURATION DECREASED 9 0.0002
608 PEMPHIGUS 2 0.0002
609 DYSARTHRIA 6 0.0002
610 DYSPNOEA EXERTIONAL 6 0.0002
611 INTESTINAL OBSTRUCTION 6 0.0002
612 BRAIN OEDEMA 2 0.0002
613 GASTRIC ULCER 3 0.0002
614 DIABETES MELLITUS 12 0.0002
615 POST PROCEDURAL COMPLICATION 3 0.0002
616 ANOREXIA 2 0.0002
617 RASH GENERALISED 4 0.0002
618 EAR PAIN 3 0.0002
619 NASAL CONGESTION 9 0.0002
620 IMPAIRED HEALING 5 0.0002
621 ORAL CANDIDIASIS 2 0.0002
622 PULMONARY CONGESTION 2 0.0002
623 CATARACT 9 0.0002
624 ADVERSE REACTION 2 0.0002
625 VIRAL INFECTION 5 0.0002
626 FUNGAL INFECTION 5 0.0001
627 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
628 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
629 FEELING HOT 9 0.0001
630 CORONARY ARTERY OCCLUSION 2 0.0001
631 RESPIRATORY DISTRESS 4 0.0001
632 MASS 2 0.0001
633 LYMPHOPENIA 2 0.0001
634 LYMPHADENOPATHY 5 0.0001
635 SINUS TACHYCARDIA 2 0.0001
636 MUSCULAR WEAKNESS 16 0.0001
637 LEUKOPENIA 7 0.0001
638 RED BLOOD CELL COUNT DECREASED 4 0.0001
639 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
640 HYPERSOMNIA 4 0.0001
641 CARDIOGENIC SHOCK 2 0.0001
642 SKIN CANCER 3 0.0001
643 MYELOSUPPRESSION 5 0.0001
644 PARAESTHESIA ORAL 2 0.0001
645 HYPOKINESIA 2 0.0001
646 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
647 FLUID OVERLOAD 2 0.0001
648 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
649 ACUTE MYOCARDIAL INFARCTION 4 0.0001
650 NASOPHARYNGITIS 25 0.0001
651 RENAL FAILURE 18 0.0001
652 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
653 CARDIOMYOPATHY 2 0.0001
654 TOOTH DISORDER 3 0.0001
655 IMMUNODEFICIENCY 2 0.0001
656 HAEMORRHAGE INTRACRANIAL 2 0.0001
657 HYPOAESTHESIA ORAL 2 0.0001
658 ECONOMIC PROBLEM 2 0.0001
659 THERAPEUTIC RESPONSE DECREASED 8 0.0001
660 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
661 OSTEOPENIA 2 0.0001
662 MUSCLE TWITCHING 3 0.0001
663 LYMPHOMA 2 0.0001
664 ANKLE FRACTURE 2 0.0001
665 TENDONITIS 2 0.0001
666 ABDOMINAL PAIN 30 0.0001
667 LUNG INFECTION 2 0.0001
668 THERAPY PARTIAL RESPONDER 2 0.0001
669 BASAL CELL CARCINOMA 2 0.0001
670 AFFECTIVE DISORDER 1 0.0001
671 CYANOSIS 2 0.0001
672 DIARRHOEA 82 0.0001
673 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
674 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
675 PREMATURE DELIVERY 2 0.0001
676 SCIATICA 2 0.0001
677 NEUTROPENIA 17 0.0001
678 DIABETIC KETOACIDOSIS 3 0.0001
679 SENSORY DISTURBANCE 2 0.0001
680 NIGHT SWEATS 4 0.0001
681 LACTIC ACIDOSIS 4 0.0001
682 PRESYNCOPE 3 0.0001
683 ENCEPHALOPATHY 3 0.0001
684 OSTEONECROSIS 4 0.0001
685 VOMITING 57 0.0001
686 PHOTOSENSITIVITY REACTION 2 0.0001
687 VISUAL ACUITY REDUCED 4 0.0001
688 CYTOMEGALOVIRUS INFECTION 2 0.0001
689 HYPOAESTHESIA 18 0.0001
690 COAGULOPATHY 2 0.0001
691 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
692 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
693 CHEST PAIN 22 0.0001
694 HAEMATEMESIS 3 0.0001
695 WHEEZING 7 0.0001
696 OSTEOARTHRITIS 5 0.0001
697 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
698 FALL 39 0.0001
699 SCAR 2 0.0001
700 VISION BLURRED 16 0.0001
701 INSOMNIA 31 0.0001
702 RECTAL HAEMORRHAGE 5 0.0001
703 SKIN ULCER 3 0.0001
704 PARANOIA 2 0.0001
705 DYSPHAGIA 11 0.0001
706 PULMONARY EMBOLISM 11 0.0001
707 ASTHMA 13 0.0001
708 MUSCULOSKELETAL STIFFNESS 10 0.0001
709 COLD SWEAT 2 0.0001
710 EAR INFECTION 3 0.0001
711 GALLBLADDER DISORDER 2 0.0001
712 THIRST 2 0.0001
713 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
714 GOUT 2 0.0001
715 ANAL INCONTINENCE 1 0.0001
716 FREQUENT BOWEL MOVEMENTS 3 0.0001
717 SYNOVITIS 2 0.0001
718 OSTEOMYELITIS 2 0.0001
719 BONE DISORDER 2 0.0001
720 SKIN DISCOLOURATION 5 0.0001
721 DYSURIA 4 0.0001
722 ANAPHYLACTIC REACTION 6 0.0001
723 HYPERTENSION 23 0.0001
724 DIVERTICULITIS 3 0.0001
725 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
726 INFLUENZA 12 0.0001
727 EYE SWELLING 4 0.0001
728 NECK PAIN 6 0.0001
729 SINUSITIS 11 0.0001
730 COGNITIVE DISORDER 5 0.0001
731 ALOPECIA 21 0.0001
732 FRACTURE 2 0.0001
733 ARRHYTHMIA 5 0.0001
734 OCULAR HYPERAEMIA 5 0.0001
735 CONDITION AGGRAVATED 32 0.0001
736 PRODUCTIVE COUGH 5 0.0001
737 INCREASED APPETITE 2 0.0001
738 HERPES ZOSTER 6 0.0001
739 BALANCE DISORDER 9 0.0001
740 GENERAL PHYSICAL HEALTH DETERIORATION 12 0.0001
741 HERNIA 2 0.0001
742 COUGH 29 0.0001
743 PRESCRIBED OVERDOSE 2 0.0001
744 DYSSTASIA 3 0.0001
745 ATRIAL FIBRILLATION 10 0.0001
746 DISABILITY 2 0.0001
747 HAEMATOCRIT DECREASED 2 0.0001
748 PRESCRIBED UNDERDOSE 2 0.0001
749 INJURY 7 0.0001
750 HEPATIC FAILURE 3 0.0001
751 FULL BLOOD COUNT DECREASED 2 0.0001
752 PRODUCT PHYSICAL ISSUE 2 0.0001
753 ILL-DEFINED DISORDER 6 0.0001
754 DRY MOUTH 8 0.0001
755 PSORIATIC ARTHROPATHY 4 0.0001
756 BONE MARROW FAILURE 2 0.0001
757 THROMBOCYTOPENIA 11 0.0001
758 PRODUCT PREPARATION ERROR 2 0.0001
759 NAUSEA 77 0.0001
760 RIB FRACTURE 2 0.0001
761 OROPHARYNGEAL PAIN 9 0.0001
762 CARDIAC ARREST 8 0.0001
763 INFLAMMATION 5 0.0001
764 PERITONITIS 2 0.0001
765 POLLAKIURIA 4 0.0001
766 ABDOMINAL DISTENSION 10 0.0001
767 URTICARIA 16 0.0001
768 RENAL FAILURE ACUTE 4 0.0001
769 EATING DISORDER 2 0.0001
770 RETCHING 2 0.0001
771 JOINT INJURY 2 0.0001
772 CONTUSION 9 0.0001
773 IRRITABLE BOWEL SYNDROME 2 0.0001
774 WEIGHT DECREASED 26 0.0001
775 DISEASE PROGRESSION 11 0.0001
776 HYPOACUSIS 4 0.0001
777 HALLUCINATION 7 0.0001
778 PRURITUS GENERALISED 2 0.0001
779 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
780 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
781 DYSPNOEA 52 0.0001
782 TREATMENT NONCOMPLIANCE 5 0.0001
783 INTENTIONAL PRODUCT MISUSE 8 0.0001
784 MALAISE 40 0.0001
785 COVID-19 16 0.0001
786 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
787 DIZZINESS 45 0.0001
788 ARTHROPATHY 5 0.0001
789 COLITIS ULCERATIVE 4 0.0001
790 GLOSSODYNIA 2 0.0001
791 RASH PAPULAR 2 0.0001
792 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
793 THROAT IRRITATION 4 0.0001
794 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
795 FLUSHING 9 0.0001
796 APPLICATION SITE PRURITUS 2 0.0001
797 GASTRIC DISORDER 3 0.0001
798 SKIN IRRITATION 4 0.0001
799 RASH MACULAR 3 0.0001
800 BLOOD CHOLESTEROL INCREASED 4 0.0001
801 SWELLING 8 0.0001
802 HYPOTENSION 17 0.0001
803 PERIPHERAL SWELLING 13 0.0001
804 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
805 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
806 MENTAL IMPAIRMENT 2 0.0001
807 VERTIGO 5 0.0001
808 LUNG DISORDER 4 0.0001
809 LIVER INJURY 2 0.0001
810 PRODUCT QUALITY ISSUE 11 0.0001
811 ABNORMAL WEIGHT GAIN 1 0.0001
812 OSTEONECROSIS OF JAW 2 0.0001
813 VISUAL IMPAIRMENT 10 0.0001
814 APPLICATION SITE IRRITATION 1 0.0001
815 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
816 PRODUCT USE ISSUE 15 0.0001
817 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
818 TREMOR 13 0.0001
819 INJECTION SITE SWELLING 6 0.0001
820 HEPATITIS 2 0.0001
821 GASTROINTESTINAL DISORDER 7 0.0001
822 LOSS OF CONSCIOUSNESS 10 0.0001
823 SEIZURE 9 0.0001
824 DRUG RESISTANCE 2 0.0001
825 ANAPHYLACTIC SHOCK 2 0.0001
826 UNRESPONSIVE TO STIMULI 2 0.0001
827 BACK PAIN 18 0.0001
828 RHINORRHOEA 5 0.0001
829 HAEMATOMA 2 0.0001
830 DIPLOPIA 2 0.0001
831 AMNESIA 5 0.0001
832 MUCOSAL INFLAMMATION 2 0.0001
833 SPEECH DISORDER 4 0.0001
834 APPLICATION SITE ERYTHEMA 2 0.0001
835 JOINT STIFFNESS 2 0.0001
836 ANHEDONIA 2 0.0001
837 ABNORMAL BEHAVIOUR 3 0.0001
838 PANCREATITIS 4 0.0001
839 DRUG INTERACTION 12 0.0001
840 OFF LABEL USE 66 0.0001
841 ASTHENIA 28 0.0001
842 JAUNDICE 2 0.0001
843 DISTURBANCE IN ATTENTION 4 0.0001
844 DYSKINESIA 3 0.0001
845 LIMB INJURY 2 0.0001
846 PALLOR 2 0.0001
847 HEPATIC ENZYME INCREASED 5 0.0001
848 SKIN LESION 2 0.0001
849 MEMORY IMPAIRMENT 10 0.0001
850 INJECTION SITE REACTION 5 0.0001
851 RHABDOMYOLYSIS 3 0.0001
852 FEELING COLD 2 0.0001
853 HEADACHE 45 0.0001
854 ROAD TRAFFIC ACCIDENT 3 0.0001
855 DEMENTIA 2 0.0001
856 BURNING SENSATION 5 0.0001
857 SLEEP DISORDER 5 0.0001
858 HEART RATE INCREASED 7 0.0001
859 MYALGIA 12 0.0001
860 FLATULENCE 4 0.0001
861 DEPRESSION 16 0.0001
862 HYPERSENSITIVITY 13 0.0001
863 INFECTION 10 0.0001
864 ANOSMIA 1 0.0001
865 MENTAL DISORDER 3 0.0001
866 BONE PAIN 4 0.0001
867 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
868 CONFUSIONAL STATE 11 0.0001
869 BLADDER CANCER 4 0.0001
870 PAIN IN EXTREMITY 20 0.0001
871 URINARY INCONTINENCE 2 0.0001
872 ARTHRALGIA 28 0.0001
873 HAEMORRHAGE 7 0.0001
874 THERAPY NON-RESPONDER 3 0.0001
875 PREMATURE BABY 2 0.0001
876 APHASIA 2 0.0001
877 LACRIMATION INCREASED 2 0.0001
878 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
879 INJECTION SITE RASH 2 0.0001
880 DRUG ADMINISTRATION ERROR 2 0.0001
881 PAIN 40 0.0001
882 PRODUCT USE IN UNAPPROVED INDICATION 16 0.0001
883 RENAL DISORDER 3 0.0001
884 EXPOSURE DURING PREGNANCY 4 0.0001
885 NERVOUS SYSTEM DISORDER 2 0.0001
886 SWOLLEN TONGUE 2 0.0001
887 DISEASE RECURRENCE 3 0.0001
888 MOOD SWINGS 2 0.0001
889 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
890 MOVEMENT DISORDER 2 0.0001
891 CARDIAC FAILURE CONGESTIVE 5 0.0001
892 HIP FRACTURE 2 0.0001
893 THROMBOSIS 5 0.0001
894 SWELLING FACE 4 0.0001
895 PSORIASIS 8 0.0001
896 PRODUCT DOSE OMISSION ISSUE 18 0.0001
897 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
898 EXPIRED PRODUCT ADMINISTERED 2 0.0001
899 SYNCOPE 6 0.0001
900 MUSCLE SPASMS 11 0.0001
901 GAIT INABILITY 2 0.0001
902 PALPITATIONS 7 0.0001
903 ABDOMINAL DISCOMFORT 10 0.0001
904 SOMNOLENCE 12 0.0001
905 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
906 CEREBROVASCULAR ACCIDENT 10 0.0001
907 FEELING ABNORMAL 14 0.0001
908 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
909 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
910 WEIGHT INCREASED 13 0.0001
911 JOINT SWELLING 7 0.0001
912 NEOPLASM PROGRESSION 2 0.0001
913 HEART RATE DECREASED 2 0.0001
914 DEPRESSED MOOD 3 0.0001
915 INJECTION SITE ERYTHEMA 7 0.0001
916 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
917 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
918 INJECTION SITE PAIN 17 0.0001
919 RASH PRURITIC 3 0.0001
920 DYSGEUSIA 4 0.0001
921 AGRANULOCYTOSIS 1 0.0001
922 BREAST CANCER 5 0.0001
923 CARDIAC DISORDER 5 0.0001
924 ACNE 4 0.0001
925 FATIGUE 41 0.0001
926 CHRONIC KIDNEY DISEASE 4 0.0001
927 MIGRAINE 5 0.0001
928 LETHARGY 3 0.0001
929 PRODUCT SUBSTITUTION ISSUE 3 0.0001
930 HOSPITALISATION 8 0.0001
931 MYOCARDIAL INFARCTION 9 0.0001
932 DYSPHONIA 3 0.0001
933 PLASMA CELL MYELOMA 2 0.0001
934 DISORIENTATION 2 0.0001
935 DEATH 43 0.0000
936 DRUG DEPENDENCE 8 0.0000
937 BLINDNESS 2 0.0000
938 OSTEOPOROSIS 2 0.0000
939 ABDOMINAL PAIN UPPER 10 0.0000
940 CARDIO-RESPIRATORY ARREST 2 0.0000
941 BLOOD GLUCOSE INCREASED 9 0.0000
942 DRUG INEFFECTIVE 62 0.0000
943 DEVICE DISLOCATION 2 0.0000
944 ANXIETY 13 0.0000
945 DEVICE ISSUE 4 0.0000
946 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
947 RHEUMATOID ARTHRITIS 5 0.0000
948 SUICIDAL IDEATION 4 0.0000
949 NEPHROLITHIASIS 2 0.0000
950 TINNITUS 2 0.0000
951 CHILLS 5 0.0000
952 SKIN BURNING SENSATION 3 0.0000
953 MOBILITY DECREASED 3 0.0000
954 DRUG INTOLERANCE 4 0.0000
955 UNDERDOSE 3 0.0000
956 ABASIA 1 0.0000
957 AGEUSIA 1 0.0000
958 HOT FLUSH 3 0.0000
959 UNEVALUABLE EVENT 3 0.0000
960 FLUID RETENTION 2 0.0000
961 BLOOD PRESSURE INCREASED 6 0.0000
962 CHEST DISCOMFORT 4 0.0000
963 HYPERHIDROSIS 5 0.0000
964 ARTHRITIS 3 0.0000
965 PARAESTHESIA 6 0.0000
966 INJECTION SITE BRUISING 3 0.0000
967 PROSTATE CANCER 3 0.0000
968 GAIT DISTURBANCE 7 0.0000
969 MEDICATION ERROR 2 0.0000
970 CONVULSION 2 0.0000
971 EMOTIONAL DISTRESS 4 0.0000
972 ADVERSE EVENT 3 0.0000
973 INCORRECT DOSE ADMINISTERED 7 0.0000
974 PRODUCT DOSE OMISSION 2 0.0000
975 NEOPLASM MALIGNANT 2 0.0000
976 INJECTION SITE PRURITUS 2 0.0000
977 TOXICITY TO VARIOUS AGENTS 5 0.0000
978 ILLNESS 3 0.0000
979 OVERDOSE 6 0.0000
980 NO ADVERSE EVENT 5 0.0000
981 ACCIDENTAL OVERDOSE 1 0.0000
982 AGITATION 2 0.0000
983 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
984 INFLUENZA LIKE ILLNESS 2 0.0000
985 DRUG DOSE OMISSION 4 0.0000
986 TREATMENT FAILURE 2 0.0000
987 DRUG ABUSE 2 0.0000
988 DRUG WITHDRAWAL SYNDROME 2 0.0000
989 ANGIOEDEMA 1 0.0000
990 ADVERSE DRUG REACTION 2 0.0000